Rajesh Balakrishnan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rajesh Balakrishnan has a total of 335 co-authors. Here are the top co-authors by number of shared publications:
Selvamani Backianathan
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India
10 shared publicationsArunangshu Das
Department of Oncology Square Hospitals Limited Dhaka Bangladesh
6 shared publicationsBidoura Naznin
Department of Oncology Square Hospitals Limited Dhaka Bangladesh
6 shared publicationsPatricia Sebastian
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India
6 shared publications- Patricia Sebastian
Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India
6 shared publications Qamruzzaman Chowdhury
Department of Oncology Bangladesh Specialized Hospital Limited Dhaka Bangladesh
6 shared publications
Latest Publications
- 15 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 220, 111576
Impact of ultrahypofractionated adjuvant regional nodal radiotherapy on patient-reported quality of life: the HYPORT adjuvant trial (NCT03788213)
- 15 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 220, 111576
Impact of ultrahypofractionated adjuvant regional nodal radiotherapy on patient-reported quality of life: the HYPORT adjuvant trial (NCT03788213)
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 285-294
Influence of Setup Uncertainties: Optimizing Clinical Target Volume-to-planning Target Volume Margins in Total Marrow and Lymphoid Irradiation
Background: Total Marrow and Lymphoid Irradiation (TMLI) is an advanced alternative to traditional Total Body Irradiation, aiming to reduce toxicities while maintaining treatment efficacy. Aim: This study evaluates setup uncertainties and their impact on clinical target volume (CTV) to planning target volume (PTV) in patients undergoing Total Marrow and Lymphoid Irradiation using a linear accelerator-based volumetric modulated arc therapy (VMAT). Materials and Methods: Setup deviations were analyzed for 15 patients using cone-beam CT image guidance across multiple isocenters. Systematic and random errors were computed for each anatomical region, and CTV-to-PTV margins were estimated using ICRU 62, Stroom’s, and van Herk’s formulas. Average shifts and 3D displacement vectors were quantified across the skull, thorax, abdomen, pelvis, and extremities. Results: Setup uncertainties were site dependent, with the thorax showing the largest systematic error (3.9 mm) and the leg the largest random error (2.6 mm). The mean 3D displacement vector ranged from 3.3 mm (pelvis) to 6.8 mm (leg). Based on systematic and random error analysis, differential PTV margins of 3 mm, for skull, 5 mm for thorax, abdomen and pelvis, and 10 mm for extremities were determined to maintain adequate dose coverage. Conclusion: VMAT-based TMLI requires region-specific margins to account for setup uncertainties, particularly in extremities. Image-guided adaptive strategies can optimize target coverage while minimizing normal tissue exposure. Precise image guidance and tailored margins are crucial for maximizing treatment efficacy and minimizing side effects in TMLI.
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 285-294
Open AccessInfluence of Setup Uncertainties: Optimizing Clinical Target Volume-to-planning Target Volume Margins in Total Marrow and Lymphoid Irradiation
Background: Total Marrow and Lymphoid Irradiation (TMLI) is an advanced alternative to traditional Total Body Irradiation, aiming to reduce toxicities while maintaining treatment efficacy. Aim: This study evaluates setup uncertainties and their impact on clinical target volume (CTV) to planning target volume (PTV) in patients undergoing Total Marrow and Lymphoid Irradiation using a linear accelerator-based volumetric modulated arc therapy (VMAT). Materials and Methods: Setup deviations were analyzed for 15 patients using cone-beam CT image guidance across multiple isocenters. Systematic and random errors were computed for each anatomical region, and CTV-to-PTV margins were estimated using ICRU 62, Stroom’s, and van Herk’s formulas. Average shifts and 3D displacement vectors were quantified across the skull, thorax, abdomen, pelvis, and extremities. Results: Setup uncertainties were site dependent, with the thorax showing the largest systematic error (3.9 mm) and the leg the largest random error (2.6 mm). The mean 3D displacement vector ranged from 3.3 mm (pelvis) to 6.8 mm (leg). Based on systematic and random error analysis, differential PTV margins of 3 mm, for skull, 5 mm for thorax, abdomen and pelvis, and 10 mm for extremities were determined to maintain adequate dose coverage. Conclusion: VMAT-based TMLI requires region-specific margins to account for setup uncertainties, particularly in extremities. Image-guided adaptive strategies can optimize target coverage while minimizing normal tissue exposure. Precise image guidance and tailored margins are crucial for maximizing treatment efficacy and minimizing side effects in TMLI.
- 7 January 2026
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (8) , 1-8
Dermatofibroasarcoma Protuberans (DFSP) of the Breast: An Eight Case Series From A Single Institution
- 7 January 2026
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (8) , 1-8
Dermatofibroasarcoma Protuberans (DFSP) of the Breast: An Eight Case Series From A Single Institution
- Open Access
- 11 December 2025
- Published by Wiley
Whispers in the Windpipe: Rare cases of Tracheal Plasmacytoma from a Tertiary Care Centre with Literature Review
- 11 December 2025
- Published by Wiley
Open AccessWhispers in the Windpipe: Rare cases of Tracheal Plasmacytoma from a Tertiary Care Centre with Literature Review
- Open Access
- 16 April 2025
- Published by Wiley
Outcomes of infant medulloblastoma treated with standard dose chemotherapy-A single institutional experience from a Low middle income country
Background Infant medulloblastoma (iMBL) are predominantly desmoplastic nodular (DN) or Medulloblastoma with Extensive Nodularity (MBEN) histology, Sonic Hedgehog (SHH) driven. Intensified chemotherapy (intraventricular chemotherapy or high-dose chemotherapy with autologous stem cell rescue) is recommended to compensate the omission of radiation. This study aims to analyse the outcomes of iMBL treated without treatment intensification. Methods This retrospective study was done on 28 patients with iMBL (children with medulloblastoma Results The median age at diagnosis and duration of symptoms were 24.5 months and 1 month, respectively. Vomiting (82%) and ataxia (71.4%) were the common presentations. Ventriculoperitoneal shunt or endoscopic 3 rd ventriculostomy was done in 57% patients. Twenty-four patients (~86%) underwent gross/near total resection. The most common surgical complication was cerebellar mutism (n=6, 21%). Half of the cohort had non-metastatic disease. Sixteen patients had DN/MBEN histology. Only 68%(n=19) opted to continue adjuvant therapy. Chemotherapy protocols used were Baby SFOP, HIT SKK and modified Packers. One fourth (n=7) received radiation (DN/MBEN=3, other histology=4) after 3 years of age. There was no treatment related mortality. The 5-year EFS of patients who received adjuvant treatment, DN/MBEN, non-DN/MBEN histology were 70%, 82.5% and 35.7%, respectively. Conclusions Managing medulloblastoma in infants is challenging in LMIC as significant proportion of families opt against adjuvant treatment. Although traditionally iMBL considered high risk, good outcomes can be achieved with non-intensified therapy in DN/MBEN subgroup.
- 16 April 2025
- Published by Wiley
Open AccessOutcomes of infant medulloblastoma treated with standard dose chemotherapy-A single institutional experience from a Low middle income country
Background Infant medulloblastoma (iMBL) are predominantly desmoplastic nodular (DN) or Medulloblastoma with Extensive Nodularity (MBEN) histology, Sonic Hedgehog (SHH) driven. Intensified chemotherapy (intraventricular chemotherapy or high-dose chemotherapy with autologous stem cell rescue) is recommended to compensate the omission of radiation. This study aims to analyse the outcomes of iMBL treated without treatment intensification. Methods This retrospective study was done on 28 patients with iMBL (children with medulloblastoma Results The median age at diagnosis and duration of symptoms were 24.5 months and 1 month, respectively. Vomiting (82%) and ataxia (71.4%) were the common presentations. Ventriculoperitoneal shunt or endoscopic 3 rd ventriculostomy was done in 57% patients. Twenty-four patients (~86%) underwent gross/near total resection. The most common surgical complication was cerebellar mutism (n=6, 21%). Half of the cohort had non-metastatic disease. Sixteen patients had DN/MBEN histology. Only 68%(n=19) opted to continue adjuvant therapy. Chemotherapy protocols used were Baby SFOP, HIT SKK and modified Packers. One fourth (n=7) received radiation (DN/MBEN=3, other histology=4) after 3 years of age. There was no treatment related mortality. The 5-year EFS of patients who received adjuvant treatment, DN/MBEN, non-DN/MBEN histology were 70%, 82.5% and 35.7%, respectively. Conclusions Managing medulloblastoma in infants is challenging in LMIC as significant proportion of families opt against adjuvant treatment. Although traditionally iMBL considered high risk, good outcomes can be achieved with non-intensified therapy in DN/MBEN subgroup.
- Open Access
- 16 October 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (1) , 22.e1-22.e10
Total Marrow and Lymphoid Irradiation (TMLI) Is Associated with Good Early Outcomes in Patients Undergoing Matched Sibling Donor and Haplo-identical Transplants for Acute Lymphoblastic Leukemia
- 16 October 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (1) , 22.e1-22.e10
Open AccessTotal Marrow and Lymphoid Irradiation (TMLI) Is Associated with Good Early Outcomes in Patients Undergoing Matched Sibling Donor and Haplo-identical Transplants for Acute Lymphoblastic Leukemia
- Open Access
- 26 September 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (9) , e70020
Case Report: Primary Squamous Cell Carcinoma of the Orbit in a Patient With Carney's Syndrome Treated With Multidisciplinary Approaches
Background: Squamous cell carcinoma (SCC) is a rare malignancy of invasive epithelium with keratinocyte differentiation, and it is the most common form of eyelid malignant neoplasm, comprising 5%–10% of malignancies. While SCC rarely affects the orbit, it may be involved through local invasion from a cutaneous primary site or extension by perineural invasion. Only 12 cases of primary orbital SCC have been reported until now. Here, we present a case of primary carcinoma of the right orbit with coexisting Carney's syndrome, a rare genetic disorder associated with multiple endocrine neoplasias (MEN) syndromes.Case: A 62‐year‐old South Asian male presented with a painful swelling in the lateral aspect of the right eyebrow and protrusion of the eyeball in August 2020. He had a history of excision of Right atrial Myxoma in March 2020. Orbital computerized tomography (CT) and positron emission tomography (PET‐CT) scans revealed an enhancing soft tissue lesion in the right orbit with the involvement of frontal and ethmoid sinuses. Biopsy confirmed HPV‐related poorly differentiated SCC, positive for HPV‐related markers. The patient received concurrent chemo irradiation with Cisplatin. Follow‐up PET‐CT done 3 months later showed a new lesion appeared in the right orbital region and right lobe of thyroid. Later had surgical excision and total thyroidectomy, and histopathological examination (HPE) from orbit was reported as invasive SCC and from the thyroid was reported as synchronous papillary thyroid cancer. The patient's proptosis resolved, and subsequent PET‐CT and magnetic resonance imaging (MRI) scans did not show any residual or recurrent disease.Conclusion: Primary SCC of the orbit is an extremely rare disease, and this case report presents the 13th reported case and the first one associated with Carney's syndrome. As there is no standard treatment regimen for primary SCC of the orbit, this case highlights the use of multimodality treatment, including surgical excision and chemo irradiation. The findings emphasize the importance of early detection and management of this uncommon and life‐threatening condition, providing hope for patients and aiding in the prevention of recurrence.
- 26 September 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (9) , e70020
Open AccessCase Report: Primary Squamous Cell Carcinoma of the Orbit in a Patient With Carney's Syndrome Treated With Multidisciplinary Approaches
Background: Squamous cell carcinoma (SCC) is a rare malignancy of invasive epithelium with keratinocyte differentiation, and it is the most common form of eyelid malignant neoplasm, comprising 5%–10% of malignancies. While SCC rarely affects the orbit, it may be involved through local invasion from a cutaneous primary site or extension by perineural invasion. Only 12 cases of primary orbital SCC have been reported until now. Here, we present a case of primary carcinoma of the right orbit with coexisting Carney's syndrome, a rare genetic disorder associated with multiple endocrine neoplasias (MEN) syndromes.Case: A 62‐year‐old South Asian male presented with a painful swelling in the lateral aspect of the right eyebrow and protrusion of the eyeball in August 2020. He had a history of excision of Right atrial Myxoma in March 2020. Orbital computerized tomography (CT) and positron emission tomography (PET‐CT) scans revealed an enhancing soft tissue lesion in the right orbit with the involvement of frontal and ethmoid sinuses. Biopsy confirmed HPV‐related poorly differentiated SCC, positive for HPV‐related markers. The patient received concurrent chemo irradiation with Cisplatin. Follow‐up PET‐CT done 3 months later showed a new lesion appeared in the right orbital region and right lobe of thyroid. Later had surgical excision and total thyroidectomy, and histopathological examination (HPE) from orbit was reported as invasive SCC and from the thyroid was reported as synchronous papillary thyroid cancer. The patient's proptosis resolved, and subsequent PET‐CT and magnetic resonance imaging (MRI) scans did not show any residual or recurrent disease.Conclusion: Primary SCC of the orbit is an extremely rare disease, and this case report presents the 13th reported case and the first one associated with Carney's syndrome. As there is no standard treatment regimen for primary SCC of the orbit, this case highlights the use of multimodality treatment, including surgical excision and chemo irradiation. The findings emphasize the importance of early detection and management of this uncommon and life‐threatening condition, providing hope for patients and aiding in the prevention of recurrence.
- Open Access
- 13 March 2024
- Published by Wiley
Case Report: Primary Squamous Cell Carcinoma of the Orbit in a patient with Carney’s syndrome treated with multidisciplinary approaches
Introduction: Squamous cell carcinoma (SCC) is a rare malignancy of invasive epithelium with keratinocyte differentiation, and it is the most common form of eyelid malignant neoplasm, comprising 5-10% of malignancies. While SCC rarely affects the orbit, it may be involved through local invasion from a cutaneous primary site or extension by perineural invasion. Only 11 cases of primary orbital SCC have been reported until now. Here, we present a case of primary carcinoma of the right orbit with coexisting Carney’s syndrome, a rare genetic disorder associated with multiple endocrine neoplasias (MEN) syndromes. Case: A 62-year-old south Asian male presented with a painful swelling in the lateral aspect of the right eyebrow and protrusion of the eyeball in August 2020. He had a history of excision of Right atrial Myxoma in March 2020. Orbital computerized Tomography (CT) and Positron Emission Tomography (PET-CT) scans revealed an enhancing soft tissue lesion in the right orbit with involvement of frontal and ethmoid sinuses. Biopsy confirmed HPV related poorly differentiated squamous cell carcinoma, positive for HPV-related markers. The patient received concurrent chemo irradiation with Cisplatin. Follow-up done PET-CT done 3 months later showed a new lesion appeared in the right orbital region and right lobe of thyroid. Later had surgical excision and total thyroidectomy and Histopathological examination (HPE) from orbit was reported as invasive SCC and from the thyroid was reported as synchronous papillary thyroid cancer. The patient’s proptosis resolved, and subsequent PET-CT and Magnetic Resonance Imaging (MRI) scans did not show any residual or recurrent disease. Conclusion: Primary SCC of the orbit is an extremely rare disease, and this case report presents the 12th reported case and the first one associated with Carney’s syndrome. As there is no standard treatment regimen for primary SCC of the orbit, this case highlights the use of multimodality treatment, including surgical excision and chemo irradiation. The findings emphasize the importance of early detection and management of this uncommon and life-threatening condition, providing hope for patients and aiding in the prevention of recurrence.
- 13 March 2024
- Published by Wiley
Open AccessCase Report: Primary Squamous Cell Carcinoma of the Orbit in a patient with Carney’s syndrome treated with multidisciplinary approaches
Introduction: Squamous cell carcinoma (SCC) is a rare malignancy of invasive epithelium with keratinocyte differentiation, and it is the most common form of eyelid malignant neoplasm, comprising 5-10% of malignancies. While SCC rarely affects the orbit, it may be involved through local invasion from a cutaneous primary site or extension by perineural invasion. Only 11 cases of primary orbital SCC have been reported until now. Here, we present a case of primary carcinoma of the right orbit with coexisting Carney’s syndrome, a rare genetic disorder associated with multiple endocrine neoplasias (MEN) syndromes. Case: A 62-year-old south Asian male presented with a painful swelling in the lateral aspect of the right eyebrow and protrusion of the eyeball in August 2020. He had a history of excision of Right atrial Myxoma in March 2020. Orbital computerized Tomography (CT) and Positron Emission Tomography (PET-CT) scans revealed an enhancing soft tissue lesion in the right orbit with involvement of frontal and ethmoid sinuses. Biopsy confirmed HPV related poorly differentiated squamous cell carcinoma, positive for HPV-related markers. The patient received concurrent chemo irradiation with Cisplatin. Follow-up done PET-CT done 3 months later showed a new lesion appeared in the right orbital region and right lobe of thyroid. Later had surgical excision and total thyroidectomy and Histopathological examination (HPE) from orbit was reported as invasive SCC and from the thyroid was reported as synchronous papillary thyroid cancer. The patient’s proptosis resolved, and subsequent PET-CT and Magnetic Resonance Imaging (MRI) scans did not show any residual or recurrent disease. Conclusion: Primary SCC of the orbit is an extremely rare disease, and this case report presents the 12th reported case and the first one associated with Carney’s syndrome. As there is no standard treatment regimen for primary SCC of the orbit, this case highlights the use of multimodality treatment, including surgical excision and chemo irradiation. The findings emphasize the importance of early detection and management of this uncommon and life-threatening condition, providing hope for patients and aiding in the prevention of recurrence.
- Open Access
- 25 December 2023
- Published by Elsevier in Desalination and Water Treatment
- Vol. 309, 80-83
Testing of DuPont™ B-Free™ technology in Arabic Gulf water at Sharjah Electricity & Water Authority (SEWA) Hamriyah Desalination Plant
- 25 December 2023
- Published by Elsevier in Desalination and Water Treatment
- Vol. 309, 80-83
Open AccessTesting of DuPont™ B-Free™ technology in Arabic Gulf water at Sharjah Electricity & Water Authority (SEWA) Hamriyah Desalination Plant
- 14 July 2023
- Published by Elsevier in World Neurosurgery
- Vol. 178, e189-e201
Correlation Between Post-Radiosurgery Perinidal Hyperintensity and AVM Obliteration Following LINAC-Based Stereotactic Radiosurgery
- 14 July 2023
- Published by Elsevier in World Neurosurgery
- Vol. 178, e189-e201
Correlation Between Post-Radiosurgery Perinidal Hyperintensity and AVM Obliteration Following LINAC-Based Stereotactic Radiosurgery